Insider Trades43 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 13, 2026 | Buy | ALT | Jerome Benedict Durso | President and CEO | 15,000 | $2.95 | $612.7M | -51.09% | +23.05% | $44.3K | +31.58% | — | Trim |
| Jul 31, 2026 | Buy | ALT | M Scot Roberts | Chief Scientific Officer | 875 | $2.41 | $612.7M | -51.09% | +23.05% | $2.1K | +0.78% | — | Trim |
| Jul 31, 2026 | Buy | ALT | Gregory L Weaver | Chief Financial Officer | 1,753 | $2.41 | $612.7M | -51.09% | +23.05% | $4.2K | +4.60% | — | Trim |
| Apr 1, 2026 | Buy | ALT | Gregory L Weaver | Chief Financial Officer | 10,000 | $3.15 | $612.7M | -51.09% | +23.05% | $31.5K | +35.62% | — | Trim |
| Apr 1, 2026 | Buy | ALT | Jerome Benedict Durso | President and CEO | 15,000 | $3.14 | $612.7M | -51.09% | +23.05% | $47.1K | +46.15% | — | Trim |
| Mar 6, 2026 | Buy | ALT | Gregory L Weaver | Chief Financial Officer | 5,000 | $3.54 | $612.7M | -51.09% | +23.05% | $17.7K | +21.67% | — | Trim |
| Mar 6, 2026 | Buy | ALT | Jerome Benedict Durso | President and CEO | 20,000 | $3.54 | $612.7M | -51.09% | +23.05% | $70.8K | +160.00% | — | Trim |
| Jan 31, 2026 | Buy | ALT | Raymond M Jordt | Chief Business Officer | 4,571 | $3.07 | $612.7M | -51.09% | +23.05% | $14.0K | +6.97% | — | Trim |
| Jan 30, 2026 | Buy | ALT | M Scot Roberts | Chief Scientific Officer | 10,755 | $4.28 | $612.7M | -51.09% | +23.05% | $46.0K | +0.11% | — | Trim |
| Jan 27, 2026 | Sell | ALT | Raymond M Jordt | Chief Business Officer | 4,229 | $6.18 | $612.7M | -51.09% | +23.05% | $26.1K | -3.60% | — | Trim |
| Jan 27, 2026 | Sell | ALT | M Scot Roberts | Chief Scientific Officer | 4,748 | $6.18 | $612.7M | -51.09% | +23.05% | $29.3K | -3.21% | — | Trim |
| Jan 25, 2026 | Sell | ALT | Raymond M Jordt | Chief Business Officer | 3,855 | $5.50 | $612.7M | -51.09% | +23.05% | $21.2K | -4.43% | — | Trim |
| Jan 25, 2026 | Sell | ALT | M Scot Roberts | Chief Scientific Officer | 4,373 | $5.50 | $612.7M | -51.09% | +23.05% | $24.1K | -3.71% | — | Trim |
| Jan 1, 2026 | Sell | ALT | Raymond M Jordt | Chief Business Officer | 2,475 | $3.61 | $612.7M | -51.09% | +23.05% | $8.9K | -4.50% | — | Trim |
| Nov 11, 2025 | Sell | ALT | Gregory L Weaver | Chief Financial Officer | 5,672 | $4.28 | $612.7M | -51.09% | +23.05% | $24.3K | -6.67% | — | Trim |
| Jul 31, 2025 | Buy | ALT | M Scot Roberts | Chief Scientific Officer | 846 | $3.14 | $612.7M | -51.09% | +23.05% | $2.7K | +1.16% | — | Trim |
| Jul 31, 2025 | Buy | ALT | Raymond M Jordt | Chief Business Officer | 1,368 | $3.14 | $612.7M | -51.09% | +23.05% | $4.3K | +3.92% | — | Trim |
| Jul 31, 2025 | Buy | ALT | Matthew Scott Harris | Chief Medical Officer | 2,018 | $3.14 | $612.7M | -51.09% | +23.05% | $6.3K | +14.34% | — | Trim |
| Mar 13, 2025 | Buy | ALT | Gregory L Weaver | Chief Financial Officer | 10,000 | $5.20 | $612.7M | -51.09% | +23.05% | $52.0K | — | — | Trim |
| Mar 7, 2025 | Sell | ALT | Matthew Scott Harris | Chief Medical Officer | 67,787 | $5.57 | $612.7M | -51.09% | +23.05% | $377.6K | -82.81% | — | Trim |
| Jan 31, 2025 | Buy | ALT | Raymond M Jordt | Chief Business Officer | 2,614 | $5.18 | $612.7M | -51.09% | +23.05% | $13.5K | +8.10% | — | Trim |
| Jan 30, 2025 | Sell | ALT | M Scot Roberts | Chief Scientific Officer | 10,010 | $6.27 | $612.7M | -51.09% | +23.05% | $62.8K | -1.24% | — | Trim |
| Jan 30, 2025 | Sell | ALT | Matthew Scott Harris | Chief Medical Officer | 9,895 | $6.47 | $612.7M | -51.09% | +23.05% | $64.1K | -1.82% | — | Trim |
| Jan 30, 2025 | Sell | ALT | Vipin K Garg | President and CEO | 31,319 | $6.58 | $612.7M | -51.09% | +23.05% | $206.2K | -1.58% | — | Trim |
| Jan 25, 2025 | Sell | ALT | Raymond M Jordt | Chief Business Officer | 3,862 | $6.98 | $612.7M | -51.09% | +23.05% | $27.0K | -1.18% | — | Trim |
| Jan 25, 2025 | Sell | ALT | M Scot Roberts | Chief Scientific Officer | 4,264 | $6.98 | $612.7M | -51.09% | +23.05% | $29.8K | -1.22% | — | Trim |
| Jan 25, 2025 | Sell | ALT | Matthew Scott Harris | Chief Medical Officer | 4,994 | $6.98 | $612.7M | -51.09% | +23.05% | $34.9K | -1.39% | — | Trim |
| Jan 25, 2025 | Sell | ALT | Vipin K Garg | President and CEO | 18,157 | $6.98 | $612.7M | -51.09% | +23.05% | $126.7K | -1.65% | — | Trim |
| Jan 1, 2025 | Sell | ALT | Raymond M Jordt | Chief Business Officer | 2,485 | $7.21 | $612.7M | -51.09% | +23.05% | $17.9K | -5.81% | — | Trim |
| Jul 31, 2024 | Buy | ALT | M Scot Roberts | Chief Scientific Officer | 650 | $5.41 | $612.7M | -51.09% | +23.05% | $3.5K | +1.52% | — | Trim |
| Jul 31, 2024 | Buy | ALT | Raymond M Jordt | Chief Business Officer | 917 | $5.41 | $612.7M | -51.09% | +23.05% | $5.0K | +6.67% | — | Trim |
| Jul 31, 2024 | Buy | ALT | Andrew Shutterly | Acting Chief Financial Officer | 1,259 | $5.41 | $612.7M | -51.09% | +23.05% | $6.8K | +12.45% | — | Trim |
| Jul 31, 2024 | Buy | ALT | Matthew Scott Harris | Chief Medical Officer | 1,486 | $5.41 | $612.7M | -51.09% | +23.05% | $8.0K | +2.77% | — | Trim |
| Feb 1, 2024 | Sell | ALT | M Scot Roberts | Chief Scientific Officer | 4,131 | $9.56 | $612.7M | -51.09% | +23.05% | $39.5K | -3.91% | — | Trim |
| Feb 1, 2024 | Sell | ALT | Matthew Scott Harris | Chief Medical Officer | 4,133 | $9.56 | $612.7M | -51.09% | +23.05% | $39.5K | -3.24% | — | Trim |
| Feb 1, 2024 | Sell | ALT | Vipin K Garg | President and CEO | 15,689 | $9.58 | $612.7M | -51.09% | +23.05% | $150.3K | -2.44% | — | Trim |
| Jan 31, 2024 | Buy | ALT | Raymond M Jordt | Chief Business Officer | 5,030 | $2.69 | $612.7M | -51.09% | +23.05% | $13.5K | +57.73% | — | Trim |
| Jan 30, 2024 | Buy | ALT | Richard I Eisenstadt | Chief Financial Officer | 6,796 | $4.97 | $612.7M | -51.09% | +23.05% | $33.7K | +2.21% | — | Trim |
| Jan 30, 2024 | Buy | ALT | Matthew Scott Harris | Chief Medical Officer | 5,966 | $5.92 | $612.7M | -51.09% | +23.05% | $35.3K | +0.49% | — | Trim |
| Jan 30, 2024 | Buy | ALT | M Scot Roberts | Chief Scientific Officer | 8,569 | $4.94 | $612.7M | -51.09% | +23.05% | $42.3K | +3.73% | — | Trim |
| Jan 30, 2024 | Sell | ALT | Vipin K Garg | President and CEO | 19,586 | $6.94 | $612.7M | -51.09% | +23.05% | $135.9K | -0.61% | — | Trim |
| Jan 1, 2024 | Sell | ALT | Raymond M Jordt | Chief Business Officer | 2,503 | $11.25 | $612.7M | -51.09% | +23.05% | $28.2K | -6.36% | — | Trim |
| Dec 29, 2023 | Sell | ALT | Richard I Eisenstadt | Chief Financial Officer | 3,044 | $11.25 | $612.7M | -51.09% | +23.05% | $34.2K | -4.96% | — | Trim |